BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2172939)

  • 1. Spinal cord thyrotropin releasing hormone receptors of morphine tolerant-dependent and abstinent rats.
    Rahmani NH; Gulati A; Bhargava HN
    Peptides; 1990; 11(4):693-5. PubMed ID: 2172939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of 3H-(3-MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats.
    Bhargava HN; Das S; Bansinath M; Prasad R
    Pharmacol Biochem Behav; 1989 Sep; 34(1):7-12. PubMed ID: 2516632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of morphine tolerance and abstinence on the binding of [3H]naltrexone to discrete brain regions and spinal cord of the rat.
    Reddy PL; Veeranna ; Matwyshyn GA; Thorat SN; Bhargava HN
    Gen Pharmacol; 1994 Mar; 25(2):355-61. PubMed ID: 8026736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of morphine tolerance and abstinence on the binding of [3H]MK-801 to brain regions and spinal cord of the rat.
    Gudehithlu KP; Reddy PL; Bhargava HN
    Brain Res; 1994 Mar; 639(2):269-74. PubMed ID: 7911390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of two kappa-opiate agonists, U-50,488H and U-69,593, on the binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to rat spinal cord and amygdala membranes.
    Rahmani NH; Gulati A; Bhargava HN
    Pharmacology; 1991; 43(3):156-62. PubMed ID: 1663623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of central receptors for thyrotropin-releasing hormone in kappa opiate agonist-induced abstinence in the rat.
    Bhargava HN; Gulati A; Rahmani NH
    Neuropharmacology; 1992 Feb; 31(2):137-41. PubMed ID: 1313157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar-Kyoto normotensive rats.
    Bhargava HN; Gulati A
    Pharmacology; 1988; 37(6):349-55. PubMed ID: 2854272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats.
    Bhargava HN; Gulati A
    J Pharmacol Exp Ther; 1990 Mar; 252(3):901-7. PubMed ID: 2138669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain and spinal cord 5-HT2 receptors of morphine-tolerant-dependent and -abstinent rats.
    Gulati A; Bhargava HN
    Eur J Pharmacol; 1989 Aug; 167(2):185-92. PubMed ID: 2591474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the behavioral supersensitivity of dopamine D2 receptors without receptor up-regulation in morphine-abstinent rats.
    Reddy PL; Veeranna ; Thorat SN; Bhargava HN
    Brain Res; 1993 Apr; 607(1-2):293-300. PubMed ID: 8481804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of brain and spinal cord mu-opiate receptors in morphine tolerant-dependent rats.
    Bhargava HN; Gulati A
    Eur J Pharmacol; 1990 Nov; 190(3):305-11. PubMed ID: 2176984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the binding of [3H][D-Ser2,Thr6]leucine-enkephalin and [3H][D-Pen2,D-Pen5]enkephalin to brain membranes of morphine tolerant-dependent rats.
    Bhargava HN; Gulati A; Rahmani NH
    Eur J Pharmacol; 1991 Sep; 202(3):403-8. PubMed ID: 1660817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of the binding of 3H-(3-MeHis2) thyrotropin releasing hormone to rat amygdala membranes by some naturally occurring cannabinoids.
    Bhargava HN; Gulati A
    Peptides; 1988; 9(4):771-5. PubMed ID: 2852360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel substance P binding site in rat brain regions modulates TRH receptor binding.
    Sharif NA
    Neurochem Res; 1990 Oct; 15(10):1045-9. PubMed ID: 1706485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of hypothalamic 5-HT1A receptors in morphine-abstinent rats.
    Gulati A; Bhargava HN
    Eur J Pharmacol; 1990 Jul; 182(2):253-9. PubMed ID: 2144490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats.
    Bhargava HN; Das S; Bansinath M
    Peptides; 1987; 8(2):231-5. PubMed ID: 3035513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential affinities of TRH analogs at the mammalian spinal cord TRH receptor: implications for therapy in spinal injuries.
    Sharif NA; To Z; Michel AD; Whiting RL
    Neurosci Lett; 1989 Sep; 104(1-2):183-8. PubMed ID: 2554219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analogs of thyrotropin-releasing hormone (TRH): receptor affinities in brains, spinal cords, and pituitaries of different species.
    Sharif NA; To ZP; Whiting RL
    Neurochem Res; 1991 Feb; 16(2):95-103. PubMed ID: 1652701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of N-methyl-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine.
    Bhargava HN; Reddy PL; Gudehithlu KP
    Gen Pharmacol; 1995 Jan; 26(1):131-6. PubMed ID: 7713352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of [3H][3-MeHis2]thyrotropin releasing hormone recognition sites in the rat brain by tifluadom, a kappa opiate receptor agonist.
    Das S; Bhargava HN
    Neuropharmacology; 1987 Aug; 26(8):1141-6. PubMed ID: 2889163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.